On Thursday, researchers in the Sinai App Lab at the Icahn School of Medicine at Mount Sinai have developed what’s called “RxUniverse,” the first enterprise-wide digital medicine care delivery system that lets physicians digitally prescribe “evidence-based mobile health applications” to patients at the point of care.
Why this offering and why now?
With countless mobile health apps available to consumers, there is no standardized method for providers to know which ones will clinically benefit their patients, and no way for them to share them with patients directly.
Through RxUniverse—which features a curated list of apps that have been evaluated for efficacy based on published evidence and incorporated into a digital prescription delivery system—Mount Sinai Health System aims to be the first provider network in the country to address this problem.
“RxUniverse allows physicians and other healthcare providers to seamlessly and confidently integrate evidence-based digital health tools into their practice,” said Ashish Atreja, MD, MPH, Chief Technology Innovation and Engagement Officer and Director of the Sinai AppLab, Icahn School of Medicine at Mount Sinai, “Apps have typically been recommended to patients verbally, but with the myriad of mobile health apps on the market, many with no proven evidence, it is a challenge for providers and patients. RxUniverse eliminates these uncertainties and barriers to digital medicine.”
To learn more about the RxUniverse platform, click here.